Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
STVN · against 270 other Healthcare companies of similar size
Ranked #166 of 271 · scores higher than 39% of peers · safety percentile 41
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)34 peers with a safety percentile of 40–49, including STVN · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | STVN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 267 reported | 0.29× | 0.26× | 47% | 33% | |
| BetaLower is better · 266 reported | 0.75 | 0.55 | 36% | 33% | |
| Current ratioHigher is better · 261 reported | 1.61× | 2.43× | 26% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 2.6B USD | 100 | 43 | |
| 4 | 3.6B USD | 99 | ||
| 5 | 2.2B USD | 99 | 48 | |
| 162 | 2.2B USD | 43 | 61 | |
| 163 | 21.1B HKD (≈$2.7B) | 42 | 67 | |
| 164 | 23.0B CNY (≈$3.2B) | 42 | 64 | |
| 165 | 34.9B CNY (≈$4.9B) | 41 | 16 | |
| 166 | 3.9B USD | 41 | 58 | |
| 167 | 884.9B JPY (≈$6.0B) | 41 | 61 | |
| 168 | 3.0B EUR (≈$3.3B) | 41 | 62 | |
| 169 | 23.2B CNY (≈$3.2B) | 41 | 62 | |
| 170 | 3.0B CHF (≈$3.5B) | 41 | 33 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score